Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Edoardo Cerbelli"'
Autor:
Andrea Botticelli, Alessio Cirillo, Giulia Pomati, Bruna Cerbelli, Simone Scagnoli, Michela Roberto, Alain Gelibter, Giulia Mammone, Maria Letizia Calandrella, Edoardo Cerbelli, Francesca Romana Di Pietro, Federica De Galitiis, Gaetano Lanzetta, Enrico Cortesi, Silvia Mezi, Paolo Marchetti
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-10 (2021)
Abstract Background The response to immunotherapy can be impaired by several factors including external intervention such as drug interactions with immune system. We aimed to examine the immunomodulatory action of opioids, since immune cells express
Externí odkaz:
https://doaj.org/article/09089a1b9e8140678dadcba6846eae32
Autor:
Andrea Botticelli, Alessio Cirillo, Lidia Strigari, Filippo Valentini, Bruna Cerbelli, Simone Scagnoli, Edoardo Cerbelli, Ilaria Grazia Zizzari, Carlo Della Rocca, Giulia D’Amati, Antonella Polimeni, Marianna Nuti, Marco Carlo Merlano, Silvia Mezi, Paolo Marchetti
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
ObjectiveThe monoclonal antibodies anti-programmed death protein-1 (anti–PD-1) nivolumab and pembrolizumab are the first immune checkpoint inhibitors (ICIs) approved for treatment of recurrent/metastatic head and neck carcinoma R/M HNSCC in first l
Externí odkaz:
https://doaj.org/article/be1e4202f5294d48ac18212f56a2914b
Autor:
Andrea Botticelli, Silvia Mezi, Giulia Pomati, Bruna Cerbelli, Edoardo Cerbelli, Michela Roberto, Raffaele Giusti, Alessio Cortellini, Luana Lionetto, Simone Scagnoli, Ilaria Grazia Zizzari, Marianna Nuti, Maurizio Simmaco, Paolo Marchetti
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Background: Clinical trials showed that only a subset of patients benefits from immunotherapy, suggesting the need to identify new predictive biomarker of resistance. Indoleamine-2,3-dioxygenase (IDO) has been proposed as a mechanism of resistance to
Externí odkaz:
https://doaj.org/article/b1221017e5fb41068e505c8d03321912
Autor:
Andrea Botticelli, Alessio Cirillo, Simone Scagnoli, Bruna Cerbelli, Lidia Strigari, Alessio Cortellini, Laura Pizzuti, Patrizia Vici, Federica De Galitiis, Francesca Romana Di Pietro, Edoardo Cerbelli, Michele Ghidini, Giulia D’Amati, Carlo Della Rocca, Silvia Mezi, Alain Gelibter, Raffaele Giusti, Enrico Cortesi, Paolo Antonio Ascierto, Marianna Nuti, Paolo Marchetti
Publikováno v:
Vaccines, Vol 8, Iss 2, p 203 (2020)
Immune checkpoint inhibitors have revolutionized treatment and outcome of melanoma and many other solid malignancies including non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC). Unfortunately, only a minority of patients have a long-t
Externí odkaz:
https://doaj.org/article/8e536d9f1f6744e3a9402aef800a9e12
Publikováno v:
Annali di Stomatologia, Vol 9, Iss 4 (2018)
Parapharyngeal space tumors account for about 0.5% of all head and neck cancers; the majority of these rare tumors (about 80%) are benign (1).
Externí odkaz:
https://doaj.org/article/d2fdf94d3d9541ff81d32c4d9047c83c
Autor:
Antonella Polimeni, Bruna Cerbelli, Alessio Cirillo, Andrea Botticelli, Ilaria Grazia Zizzari, Carlo Della Rocca, Lidia Strigari, Filippo Valentini, Silvia Mezi, Giulia d'Amati, Simone Scagnoli, Marianna Nuti, Marco Merlano, Edoardo Cerbelli, Paolo Marchetti
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
ObjectiveThe monoclonal antibodies anti-programmed death protein-1 (anti–PD-1) nivolumab and pembrolizumab are the first immune checkpoint inhibitors (ICIs) approved for treatment of recurrent/metastatic head and neck carcinoma R/M HNSCC in first l
Autor:
Francesca Di Pietro, Federica De Galitiis, Enrico Cortesi, Giulia Mammone, Simone Scagnoli, Giulia Pomati, Michela Roberto, Silvia Mezi, Gaetano Lanzetta, Edoardo Cerbelli, Alessio Cirillo, Paolo Marchetti, Bruna Cerbelli, Alain Gelibter, Andrea Botticelli, Maria Letizia Calandrella
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-10 (2021)
Background The response to immunotherapy can be impaired by several factors including external intervention such as drug interactions with immune system. We aimed to examine the immunomodulatory action of opioids, since immune cells express opioid re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0a4cd6554692c19567d848666345e3c
http://hdl.handle.net/11573/1529260
http://hdl.handle.net/11573/1529260
Autor:
Raffaele Giusti, Federica De Galitiis, Silvia Mezi, Paolo Marchetti, Andrea Botticelli, Enrico Cortesi, Francesca Di Pietro, Patrizia Vici, Alessio Cirillo, Giulia d'Amati, L. Pizzuti, Carlo Della Rocca, Lidia Strigari, Bruna Cerbelli, Edoardo Cerbelli, Simone Scagnoli, Marianna Nuti, Alessio Cortellini, Alain Gelibter, Paolo A. Ascierto, Michele Ghidini
Publikováno v:
Vaccines
Volume 8
Issue 2
Vaccines, Vol 8, Iss 203, p 203 (2020)
Volume 8
Issue 2
Vaccines, Vol 8, Iss 203, p 203 (2020)
Immune checkpoint inhibitors have revolutionized treatment and outcome of melanoma and many other solid malignancies including non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC). Unfortunately, only a minority of patients have a long-t
Autor:
Silvia Mezi, Simone Scagnoli, Alessio Cortellini, Andrea Botticelli, Bruna Cerbelli, Marianna Nuti, Ilaria Grazia Zizzari, Luana Lionetto, Maurizio Simmaco, Raffaele Giusti, Edoardo Cerbelli, Paolo Marchetti, Michela Roberto, Giulia Pomati
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology, Vol 11 (2020)
Background: Clinical trials showed that only a subset of patients benefits from immunotherapy, suggesting the need to identify new predictive biomarker of resistance. Indoleamine-2,3-dioxygenase (IDO) has been proposed as a mechanism of resistance to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a11e33e0a00cd114f54002e90f341879
http://hdl.handle.net/11573/1434713
http://hdl.handle.net/11573/1434713
Autor:
Ganiyat Adenike Ralitsa Adebanjo, Camilla Chello, Fabiola Luzi, Edoardo Cerbelli, Aldo Pezzuto, Alvise Sernicola, Francesca Romana Parisella, Jordi Rello, Gabriella De Marco, Antonella Tammaro
Publikováno v:
International Wound Journal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f92a9f58a355f1f4691052eb1409225
http://hdl.handle.net/11573/1396069
http://hdl.handle.net/11573/1396069